Gulshan Shaver, ATY - Singulex Inc

Singulex Inc. is at the forefront of immunodiagnostics with its revolutionary Sgx Clarity System, utilizing Single Molecule Counting technology to provide unprecedented sensitivity and precision in the detection of low-abundance biomarkers. Backed by robust clinical validation from over 110,000 patients and more than 130 independent peer-reviewed publications, Singulex is transforming healthcare by enabling clinicians to accurately identify coronary artery disease and other conditions in patients.

Committed to advancing healthcare, Singulex's fully-automated immunodiagnostics platform offers a game-changing approach to diagnostic testing, promising to distinguish healthy patients from those with underlying issues with up to 1000 times greater sensitivity than traditional methods. As the company continues to innovate and develop new technologies, it remains dedicated to improving patient outcomes and the future of medical diagnostics.

Generated from the website